PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference102 articles.
1. Identification of the von Hippel-Lindau disease tumor suppressor gene.;Latif;Science,1993
2. Mutations of the VHL tumour suppressor gene in renal carcinoma.;Gnarra;Nat Genet,1994
3. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.;Kaelin;Nat Rev Cancer,2008
4. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.;Yang;N Engl J Med,2003
5. Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival.;Escudier;J Clin Oncol,2010
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Functional implications of fumarate-induced cysteine succination;Trends in Biochemical Sciences;2024-09
2. The Role of the PAX Genes in Renal Cell Carcinoma;International Journal of Molecular Sciences;2024-06-19
3. Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel;Cancers;2024-05-25
4. Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients;Practical Laboratory Medicine;2024-05
5. Exploiting De Novo Serine Synthesis as a Metabolic Vulnerability to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3